Chairman, President and CEO of Allergan Plc (NYSE:AGN) Brent L Saunders bought 4,600 shares of AGN on 12/06/2017 at an average price of $164.74 a share. The total cost of this purchase was $757,804.
Allergan PLC is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and OTC pharmaceutical products. Allergan PLC has a market cap of $54.88 billion; its shares were traded at around $165.02 with and P/S ratio of 3.58. The dividend yield of Allergan PLC stocks is 1.70%. Allergan PLC had annual average EBITDA growth of 3.60% over the past five years.
CEO Recent Trades:
Chairman, President and CEO Brent L Saunders bought 4,600 shares of AGN stock on 12/06/2017 at the average price of $164.74. The price of the stock has increased by 0.17% since.
Directors and Officers Recent Trades:
Director Christopher J Coughlin bought 10,000 shares of AGN stock on 12/05/2017 at the average price of $163.3. The price of the stock has increased by 1.05% since.Chief Commercial Officer William Meury sold 11,807 shares of AGN stock on 12/01/2017 at the average price of $173.89. The price of the stock has decreased by 5.1% since.
For the complete insider trading history of AGN, click here
Hot Medical Stocks To Own For 2018: Skyworks Solutions, Inc.(SWKS)
- [By WWW.THESTREET.COM]
Shares rose 6.3% after hours to $159.50, and made fresh highs. They’re now up 37% on the year. iPhone/iPad suppliers also got a boost: Cirrus Logic Inc. (CRUS) rose 4.2% to $65.70, Skyworks Solutions Inc. (SWKS) rose 3.1% to $107.50, Qorvo Inc. (QRVO) rose 2.7% to $69.90, Jabil Inc. (JBL) rose 1.2% to $30.78 and Broadcom Ltd. (AVGO) rose 2.8% to $255.40.
- [By Lisa Levin] Gainers
Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
- [By Brian Feroldi]
Investing in the tech sector can be tricky. Competition tends to be fierce, which makes it difficult to stay one step ahead. Two companies that have a strong history of maintaining their edge are Skyworks Solutions(NASDAQ:SWKS)and Infinera(NASDAQ:INFN). Both of these businesses have been taking market share in their industries for years, which is impressive. But which of these two tech companies is the better investment today? Let’s review the bull thesis for each company so we can make an informed decision.
Hot Medical Stocks To Own For 2018: Caseys General Stores, Inc.(CASY)
- [By Taylor Cox]
Casey’s General Stores, Inc (NASDAQ: CASY) Q2 after hours
Secondary Offering Lockup Expirations
Athenex, Inc (NASDAQ: ATNX)
IPO Quiet Period Expirations
- [By Brian Stoffel]
For a number of years,Casey’s General Stores (NASDAQ:CASY) investors were rewarded by the small-town convenience chain’s decision to become a major vendor of pizza and other prepared foods. But with that success has come increased competition. Combined with somewhat stagnant economies in the areas that Casey’s operates — namely, towns of less than 5,000 people in middle America — the company has had trouble meeting its own expectations. That trend continued on Monday night when Casey’s announced earnings for the third quarter of its fiscal year.
- [By Chad Fraser]
One chain that continues to match up well with the above criteria is Casey’s General Stores (NasdaqGS: CASY). We last highlighted the company’s strong prospects in a December 12 Investing Daily article. Since then, the stock has risen nearly 40%.
Hot Medical Stocks To Own For 2018: Brown Forman Corporation(BF.B)
- [By Chris Lange]
The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday Brown-Forman Corp. (NYSE: BF.B) which rose nearly 7% to $66.01. The stocks 52-week range is $64.29 to $67.98. Volume was over just over 1 million compared to its average volume of 0.7 million.
Hot Medical Stocks To Own For 2018: Achillion Pharmaceuticals Inc.(ACHN)
- [By Ben Levisohn]
We updated our annual U.S. Hep C survey in early July, in order to gauge the future for Gilead, AbbVie/Enanta Pharmaceuticals (ENTA), Merck, and J&J/Achillion Pharmaceuticals (ACHN). In conjunction with script trends, physicians indicate that the market for treatment-eligible, easily accessible Hep C patients is shrinking, but that Gilead’s share of the shrinking pie is continuing to grow. With no end to script declines in sight, we are left wondering where the Hep C will bottom…
- [By Paul Ausick]
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) dropped about 6.9% Friday to post a new 52-week low of $2.69 after closing at $2.89 on Thursday. The 52-week high is $5.66. Volume was around 6.2 million, more than three times the daily average of around 1.9 million. The company had no specific news.
Hot Medical Stocks To Own For 2018: SL Green Realty Corporation(SLG)
- [By Nelson Hem]
“Manhattan on Sale? That’s the Case With Two Cheap REITS” by Andrew Bary discusses whether Manhattan-focused real estate investment trusts Vornado Realty Trust (NYSE: VNO) and SL Green Realty Corp (NYSE: SLG) could rally as the New York market firms. Both trade at a discount to the value of private-market property deals, says the article.
Hot Medical Stocks To Own For 2018: SolarWindow Technologies, Inc. (WNDW)
- [By SEEKINGALPHA.COM]
SolarWindow Technologies, Inc. (OTCQB:WNDW) is another third-party currently engaged in research and development to incorporate one of GLW’s glass products in an innovative manner. WNDW, a leading developer of transparent electricity-generating coatings for glass windows and flexible veneers, announced its plan to develop electricity-generating flexible glass. In particular, WNDW’s scientists and engineers recently applied layers of its liquid coatings onto GLW’s Willow Glass and laminated them under conditions that simulate the high pressure and temperatures of the manufacturing processes used by commercial glass and window producers. The result was a bendable glass “veneer” which generates electricity. WNDW anticipates installing these sheets of electricity-generating glass veneers over existing office tower windows, turning buildings into vertical power generators and helping decrease their carbon footprint. The company also believes that such veneers could be applied to flat and curved surfaces on automobiles, trucks, buses, airplanes, and boats to generate onboard electrical power. WNDW’s veneer products are being developed in collaboration with the U.S. Department of Energy’s National Renewable Energy Laboratory in an effort to commercialize WNDW’s products. While we saw no specific timeline for when WNDW would offer its products incorporating Willow Glass, we are once again excited by this innovative use of a GLW product.